Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02291016 · ClinicalTrials.gov registry record · NA
COPD Aerosol Study Comparing the Efficacy of Nebulizers Versus Dry Powder Inhalers
A NA study of COPD Exacerbation, sponsored by University of Tennessee Graduate School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT02291016: Completed NA study of COPD Exacerbation, sponsored by University of Tennessee Graduate School of Medicine.
NCT02291016 is a NA study of COPD Exacerbation that has completed, run by University of Tennessee Graduate School of Medicine. The registered enrollment target is 7 participants, below the 46-participant average among 3 other COPD Exacerbation trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02291016, a NA study of COPD Exacerbation, has completed, sponsored by University of Tennessee Graduate School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare drug delivery and lung function after treatment with formoterol from a nebulizer versus a dry powder inhaler (DPI) in patients recovering from severe exacerbations of COPD. This is to determine if one device is superior in providing better lung function and drug deposition in this clinical setting.
Primary Outcome
The difference between the values of area under the response curve for FEV1 from baseline through four hours (AUC FEV1 0-4h) after inhalation of formoterol with a nebulizer or a dry powder inhaler.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Formoterol
Study Locations (1)
Tennessee
- University of Tennessee Medical Center - Knoxville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-03 |
| Phase | NA |
What the finished NCT02291016 record still lists
NCT02291016 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 46-participant average among 3 other COPD Exacerbation trials with a reported enrollment target (85% lower).
The record links to 1 condition, with COPD Exacerbation appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02291016 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT02291016 about?
NCT02291016 is a clinical study titled "COPD Aerosol Study Comparing the Efficacy of Nebulizers Versus Dry Powder Inhalers". The purpose of this study is to compare drug delivery and lung function after treatment with formoterol from a nebulizer versus a dry powder inhaler (DPI) in patients recovering from severe exacerbations of COPD. This is to determine if one device is superior in providing better lung function and dr...
What is the current status of trial NCT02291016?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2015-02. Estimated completion is 2016-03.
What conditions does trial NCT02291016 study?
This clinical trial studies the following conditions: COPD Exacerbation.
What interventions are being tested in trial NCT02291016?
The interventions under investigation include: Placebo (OTHER), Formoterol (DRUG).
Who is sponsoring clinical trial NCT02291016?
This trial is sponsored by University of Tennessee Graduate School of Medicine, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02291016 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD Exacerbation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia